Half of all patients with syncope have CT head performed with a yield of 1.2% to 3.8%

IMAGE: Systematic review: Cohort studies in English/French. Two prospective, 15 retrospective, eight education department, six hospitalized, three other. view more  Credit: KIRSTY CHALLEN, B.SC., MBCHB, MRES, PH.D., LANCASHIRE TEACHING HOSPITALS, UNITED KINGDOM DES PLAINES, IL — More than half of patients with syncope underwent CT head with a diagnostic yield of 1.1 percent to 3.8 percent.…

Aethlon Medical collaborates at Colangelo golf event engaging participants for CTE studies

PHOENIX, Ariz. — May 13, 2019 — Aethlon Medical Inc. (AEMD) and its diagnostic subsidiary, Exosome Sciences, in collaboration with the Translational Genomics Research Institute (TGen) and the Prostate On-Site Project (POP), announced that Aethlon, TGen and POP will engage with participants for their studies of chronic traumatic encephalopathy (CTE) in living individuals during the…

New recommendations for a thyroid and cardiovascular disease research agenda

IMAGE: Thyroid, the official journal of the American Thyroid Association®, (ATA®) is an authoritative peer-reviewed journal published monthly online with open access options and in print. view more  Credit: (c) 2019 Mary Ann Liebert, Inc., publishers New Rochelle, NY, May 13, 2019–New Recommendations for a Thyroid and Cardiovascular Disease Research Agenda have been co-published in Thyroid®…

New insights into treatment targets for men with advanced prostate cancers

SALT LAKE CITY, UTAH, and CAMBRIDGE, MASSACHUSETTS – A study published recently in the Journal of Clinical Oncology Precision Oncology, an American Society of Clinical Oncology (ASCO) journal, outlines findings from the largest-ever prospective genomic analysis of advanced prostate cancer tumors. Using comprehensive genomic profiling (CGP) to analyze thousands of tumor samples from men with…

CDC concurs with panel led by Regenstrief scientist on misapplication of opioid guidelines

INDIANAPOLIS — The Centers for Disease Control and Prevention is clarifying its guidelines on opioid prescribing, citing the findings of a review panel led by Regenstrief Institute Research Scientist Kurt Kroenke, M.D. Dr. Kroenke and his colleagues found that many clinicians, policymakers and payers are misapplying the CDC’s guidelines, and those actions are negatively affecting…